Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.410
-0.170 (-3.71%)
At close: Jan 31, 2025, 4:00 PM
4.400
-0.010 (-0.23%)
After-hours: Jan 31, 2025, 6:50 PM EST
Vanda Pharmaceuticals Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$15.50
Upside
+251.47%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +308.16% | Jan 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +308.16% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +308.16% | Dec 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +308.16% | Oct 31, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +194.78% | Aug 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $11 | Buy | Initiates | $11 | +149.43% | Jul 11, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $24 → $12 | Strong Buy → Hold | Downgrades | $24 → $12 | +172.11% | Feb 25, 2022 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $14 | Strong Buy → Hold | Downgrades | $14 | +217.46% | Jan 14, 2021 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +217.46% | Oct 29, 2020 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $14 | Strong Buy → Hold | Downgrades | $14 | +217.46% | Jun 9, 2020 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +217.46% | Mar 12, 2020 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $19 | Hold → Strong Buy | Upgrades | $19 | +330.84% | Aug 1, 2019 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 6, 2019 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades $29 | Buy → Hold | Downgrades | $29 | +557.60% | Dec 11, 2018 |
| Citigroup | Citigroup | Strong Buy Maintains $31 → $47 | Strong Buy | Maintains | $31 → $47 | +965.76% | Dec 7, 2018 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold → Buy Upgrades $43 | Hold → Buy | Upgrades | $43 | +875.06% | Dec 4, 2018 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.